Get the full picture
Sign in to uncover key details.
Show More
Ovid Therapeutics
Manufacturing · New York, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
441 9th Ave, New York, New York, 10001, ...Phone Number
(646) 661-7661Website
www.ovidrx.comRevenue
<$5 MillionStock Symbol
OVIDIndustry
About Ovid Therapeutics
Ovid Therapeutics Inc. is a New York-based biopharmaceutical company using its BoldMedicine® approach to develop medicines that transform the lives of patients with rare neurological disorders. Ovid has a broad pipeline of potential first-in-class medicines in development. The Company's most advanced investigational medicine, OV101 (gaboxadol), is currently in clinical development for the treatment of Angelman syndrome and Fragile X syndrome. Ovid is also developing OV935 (soticlestat) in collaboration with Takeda Pharmaceutical Company Limited for the potential treatment of rare developmental and epileptic encephalopathies (DEEs).Explore more
Ovid Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Ovid Therapeutics
Compare insights from companies similar to Ovid Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Ovid Therapeutics
<$5M
11-50
Public
$420.1M
2014
CN
Claude NicaiseChief Operating Officer Head of Research & Development
Ovid Therapeutics Tech Stack
A closer look at the technologies used by Ovid Therapeutics
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Ovid Therapeutics
Sign Up For FreeTo access detailed company insights
Ovid Therapeutics Inc. is a New York-based biopharmaceutical company using its BoldMedicine® approach to develop medicines that transform the lives of patients with rare neurological disorders. Ovid has a broad pipeline of potential first-in-class medicines in development. The Company's most advanced investigational medicine, OV101 (gaboxadol), is... Read More
